Amniotic fluid embolism (AFE) is a multifactorial obstetric emergency characterized by the entry of amniotic fluid, fetal cells, and other debris into the maternal circulation, triggering a cascade of catastrophic events. This condition primarily involves the disruption of the placental-amniotic interface, allowing amniotic fluid and fetal components such as squamous cells, hair, meconium, and other substances to enter the maternal bloodstream. These materials are believed to gain access through the placental attachment, cervical veins, or uterine incisions, especially during labor, delivery, or cesarean section.
The entry of these foreign elements into the maternal circulation leads to an abnormal maternal immune response, resembling an anaphylactoid reaction. Upon reaching the pulmonary arterial system, the immune response is triggered, releasing an array of inflammatory mediators such as histamine, endothelin, and leukotrienes. This immunological reaction is responsible for the cardiovascular and pulmonary collapse that defines the first phase of AFE. In this early stage, there is intense pulmonary vasoconstriction and bronchoconstriction, leading to acute right heart failure and significant pulmonary hypertension. The right ventricle becomes dilated, resulting in tricuspid regurgitation and subsequent hypoxia due to impaired pulmonary circulation. This first phase is brief, typically 15 to 30 minutes, and it is when most deaths occur; the hemodynamic data recorded in survivors of the initial event show that the pulmonary hypertension is transient and that left ventricular failure with pulmonary edema follows as the second phase.
As the right ventricle dilates, the interventricular septum bows into the left ventricle and restricts left ventricular filling, so stroke volume falls (ventricular interdependence). Systemic hypotension then reduces right coronary perfusion of a pressure-loaded right ventricle, and circulating mediators depress the myocardium directly, so left ventricular systolic dysfunction follows. With increasing pulmonary artery pressures, cardiac output declines, which can precipitate life-threatening dysrhythmias such as ventricular fibrillation, asystole, or pulseless electrical activity. The hypoxia and cardiovascular collapse can result in profound neurological damage due to ischemia, leading to hypoxic brain injuries or multi-organ failure in survivors.

Another key pathophysiological component of AFE is the activation of the coagulation cascade, resulting in disseminated intravascular coagulation (DIC), which affects up to 80% of AFE patients. Amniotic fluid contains tissue factors with potent procoagulant properties, which can activate the clotting cascade and lead to widespread intravascular clot formation, followed by excessive fibrinolysis. This hyperactivation of the clotting system causes a severe depletion of platelets and clotting factors, culminating in coagulopathy and relentless bleeding, often manifested as uterine atony and hemorrhage. The coagulopathy typically appears within minutes of collapse and before enough blood has been lost to explain it by dilution, which is part of the research case definition; hyperfibrinolysis is prominent, and fibrinogen falls first and fastest. The resulting coagulopathy is further complicated by systemic inflammation, driven by mediators like platelet-activating factor, tumor necrosis factor-alpha (TNF-alpha), interleukins, and complement factors, which exacerbate bleeding and contribute to multi-organ dysfunction.
Histopathologically, AFE is often associated with findings such as pulmonary edema, alveolar hemorrhage, and amniotic component emboli in the lungs. Fetal squamous cells and other debris in the pulmonary vasculature were once regarded as the hallmark of AFE, but they are neither sensitive nor specific: they are difficult to find because of their size, and they have been recovered from the pulmonary circulation of pregnant women who never developed the syndrome. The diagnosis therefore rests on the clinical picture, even at autopsy. Additional autopsy findings may include myocardial infarction, acute renal failure from acute tubular necrosis, and cerebral infarctions, all of which underscore the multisystem involvement and severity of AFE. Pulmonary edema, observed in about 70% of postmortem cases, is a prevalent pathological feature of AFE, contributing to the acute respiratory failure seen in the clinical presentation.
| Stage | What happens | Consequence |
|---|---|---|
| Entry | Amniotic fluid, squamous cells, hair, meconium and other debris cross the placental-amniotic interface through the placental attachment, cervical veins or uterine incisions | Foreign material reaches the maternal pulmonary arterial system |
| Immune reaction | An anaphylactoid response releases inflammatory mediators including histamine, endothelin and leukotrienes | Intense pulmonary vasoconstriction and bronchoconstriction |
| Right heart failure | Pulmonary hypertension dilates the right ventricle | Tricuspid regurgitation and hypoxia from impaired pulmonary circulation |
| Left heart compromise | The dilated right ventricle bows the septum into the left ventricle; hypotension starves the right coronary artery and mediators depress the myocardium | Impaired left ventricular filling, then systolic dysfunction and pulmonary edema (the second phase) |
| Circulatory arrest | Rising pulmonary artery pressures drive cardiac output down | Ventricular fibrillation, asystole or pulseless electrical activity; hypoxic brain injury or multi-organ failure in survivors |
| Coagulopathy | Tissue factor in amniotic fluid activates the clotting cascade, followed by excessive fibrinolysis | DIC in up to 80% of patients — platelet and clotting factor depletion, uterine atony and relentless bleeding |